| Gina Marie Criado, RN | |
|
400 Western Ave, South Portland, ME 04106-1704 | |
| (207) 774-7111 | |
| Not Available |
| Full Name | Gina Marie Criado |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Addiction (substance Use Disorder) |
| Location | 400 Western Ave, South Portland, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982309100 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WA0400X | Registered Nurse - Addiction (substance Use Disorder) | 70029 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gina Marie Criado, RN 400 Western Ave, South Portland, ME 04106-1704 Ph: (207) 774-7111 | Gina Marie Criado, RN 400 Western Ave, South Portland, ME 04106-1704 Ph: (207) 774-7111 |
News Archive
The Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) is an independent group of experts that periodically monitors and evaluates the evolution of SARS-CoV-2 and assesses if specific mutations and combinations of mutations alter the behavior of the virus.
What started off as basic research 25 years ago has now lead to a successfully approved drug: The entry blocker bulevirtide (brand name Hepcludex, formerly known as Myrcludex B), jointly developed by researchers from Heidelberg University Hospital (UKHD) and the Medical Faculty of Heidelberg, the DZIF and other partners, has now been approved by the European Commission.
A Michigan State University researcher is challenging health standards that consider nitrates and nitrites in food to be harmful.
Researchers in the Centre for the History of Medicine at the University of Warwick are investigating the impact of solitary confinement in prisons on mental health over the last 150 years, drawing on archival evidence, including the Howard League Archives held at Warwick University's Modern Records Centre, and the memoirs of real prisoners.
The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients.
› Verified 7 days ago
Erin Garthwaite, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 400 Western Ave, South Portland, ME 04106 Phone: 207-774-7111 | |
Heather Lee Labbe, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 400 Western Ave, South Portland, ME 04106 Phone: 207-774-7111 Fax: 207-775-1985 | |
Mrs. Jennifer Lyn Skoglund, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 105 Main St, South Portland, ME 04106 Phone: 207-741-2624 | |
Stacy Lamore, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 400 Western Ave, South Portland, ME 04106 Phone: 207-741-7111 | |
Katherine J. Letourneau, AGNP-BC Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 100 Brickhill Ave Ste 304, South Portland, ME 04106 Phone: 207-761-4700 | |
Mrs. Katrina Lianne Hockey, PMHNP-BC Registered Nurse Medicare: Medicare Enrolled Practice Location: 16 Atlantic Pl, South Portland, ME 04106 Phone: 207-482-0276 | |
Ms. Bettina Pearson, RN, IBCLC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 98 Parrott St, South Portland, ME 04106 Phone: 207-775-6455 |